Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shannon Fortin

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Neuro-Oncology Practice|May 31, 2021
Assessing the utility and attitudes toward molecular testing in neuro-oncology: a survey of the Society for Neuro-Oncology membersShannon Fortin Ensign, Maya Hrachova, Susan Chang, et al.
Brain Pathology (Zurich, Switzerland)|April 18, 2009
Galectins and gliomasMarie Le Mercier, Shannon Fortin, Véronique Mathieu, et al.
Medicine|March 1, 2019
Characteristics of the modern-day physician house callShannon Fortin Ensign, Katie Baca-Motes, Steven R Steinhubl, et al.
Journal of Immunotherapy and Precision Oncology|December 25, 2023
Histiocytic Sarcoma Treated with Pembrolizumab: A Case Report and Literature ReviewDaniel Huff, Shannon Fortin Ensign, Margaret S Ryan, et al.
Pigment Cell & Melanoma Research|October 31, 2019
Genomic analysis reveals low tumor mutation burden which may be associated with GNAQ/11 alteration in a series of primary leptomeningeal melanomasShannon Fortin Ensign, Kathryn Bollin, Sherri Z Millis, et al.
Brain Pathology (Zurich, Switzerland)|October 25, 2008
Galectin-1 is implicated in the protein kinase C epsilon/vimentin-controlled trafficking of integrin-beta1 in glioblastoma cellsShannon Fortin, Marie Le Mercier, Isabelle Camby, et al.
Nuclear Medicine Communications|May 9, 2023
Clinical utility of somatostatin receptor positron emission tomography imaging biomarkers for characterization of meningioma among incidental central nervous system lesionsShannon Fortin Ensign, Muskan Agarwal, Molly Klanderman, et al.
The Lancet. Infectious Diseases|November 21, 2018
Severe CNS angiostrongyliasis in a young marine: a case report and literature reviewLiane McAuliffe, Shannon Fortin Ensign, Derek Larson, et al.
Molecular Cancer|September 13, 2012
The small GTPase RhoG mediates glioblastoma cell invasionAneta Kwiatkowska, Sebastien Didier, Shannon Fortin, et al.
Neoplasia (New York, N.Y.)|May 5, 2009
Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expressionMarie Le Mercier, Shannon Fortin, Véronique Mathieu, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Neuro-Oncology Practice|May 31, 2021
Assessing the utility and attitudes toward molecular testing in neuro-oncology: a survey of the Society for Neuro-Oncology membersShannon Fortin Ensign, Maya Hrachova, Susan Chang, et al.
Brain Pathology (Zurich, Switzerland)|April 18, 2009
Galectins and gliomasMarie Le Mercier, Shannon Fortin, Véronique Mathieu, et al.
Medicine|March 1, 2019
Characteristics of the modern-day physician house callShannon Fortin Ensign, Katie Baca-Motes, Steven R Steinhubl, et al.
Journal of Immunotherapy and Precision Oncology|December 25, 2023
Histiocytic Sarcoma Treated with Pembrolizumab: A Case Report and Literature ReviewDaniel Huff, Shannon Fortin Ensign, Margaret S Ryan, et al.
Pigment Cell & Melanoma Research|October 31, 2019
Genomic analysis reveals low tumor mutation burden which may be associated with GNAQ/11 alteration in a series of primary leptomeningeal melanomasShannon Fortin Ensign, Kathryn Bollin, Sherri Z Millis, et al.
Brain Pathology (Zurich, Switzerland)|October 25, 2008
Galectin-1 is implicated in the protein kinase C epsilon/vimentin-controlled trafficking of integrin-beta1 in glioblastoma cellsShannon Fortin, Marie Le Mercier, Isabelle Camby, et al.
Nuclear Medicine Communications|May 9, 2023
Clinical utility of somatostatin receptor positron emission tomography imaging biomarkers for characterization of meningioma among incidental central nervous system lesionsShannon Fortin Ensign, Muskan Agarwal, Molly Klanderman, et al.
The Lancet. Infectious Diseases|November 21, 2018
Severe CNS angiostrongyliasis in a young marine: a case report and literature reviewLiane McAuliffe, Shannon Fortin Ensign, Derek Larson, et al.
Molecular Cancer|September 13, 2012
The small GTPase RhoG mediates glioblastoma cell invasionAneta Kwiatkowska, Sebastien Didier, Shannon Fortin, et al.
Neoplasia (New York, N.Y.)|May 5, 2009
Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expressionMarie Le Mercier, Shannon Fortin, Véronique Mathieu, et al.
Pageof 2